Madison Avenue Securities shows up on BrokerCheck beside a pending customer arbitration naming Wesley Palmer (CRD 6433982). The product at issue is a BDC or interval fund. The allegations are unproven, and no party has paid anything on the claim.

Soreide Law Group is evaluating claims against brokers and financial advisors who may have made unsuitable recommendations for investors to buy Carter Validus Mission Critical REIT products.
Apparently, Carter Validus (CV) has offered investors non-traded real estate investment trust programs including Carter Validus Mission Critical REIT (“CVMCR”) and Carter Validus Mission Critical REIT II (“CVMCR”). The company claims that its programs support providing investors regular distributions, preservation of capital contributions, and capital appreciation with a focus on stable, diversified assets.
The original offering price for Carter Validus Mission Critical REITs was $10.00 per share. Apparently, as of June 30, 2018, Carter Validus claimed that its NAV is just $5.33. Moreover, at least one secondary market company – Central Trade & Transfer, LLC - who operates an automated auction Website for buyers and sellers of illiquid real estate investment trust shares – listed Carter Validus Mission Critical REIT shares for nearly sixty percent less than the original offering price.
Notably, the Carter Validus Mission Critical REIT recently disclosed to the Securities and Exchange Commission (“SEC”) that it cannot honor all repurchase requests for the 2019 Q1 repurchase date. This comes after the board of directors suspended its share repurchase program in 2018. Therefore, some investors who have requested the repurchase of their shares may have to wait longer before they can sell them because there is no public market for its shares.
Brokers and financial advisors may have sold Carter Validus Mission Critical REITs without informing investors about its downsides. Specifically, investors have to deal with the risk that the proceeds from a redemption of CV Mission Critical REIT shares may be less than the original amount invested. Moreover, brokers and financial advisors sometimes overlook due diligence on the investments they sell to investors. Because of this, some brokers and advisors lack a reasonable basis to believe that the investments they sell are suitable for investors. Given the high commissions and fees associated with REITS, there is an elevated risk that brokers and advisors may make inappropriate or unsuitable sales.

Have you experienced losses by purchasing Carter Validus Mission Critical REIT from your broker or advisor? If so, contact Soreide Law Group at (888) 760-6552 and speak with experienced counsel about a possible recovery of your investment losses. Soreide Law Group represents clients on a contingency fee basis and advance all costs. The firm has recovered millions of dollars for investors who have suffered losses due to misconduct of brokers and brokerage firms.
Madison Avenue Securities shows up on BrokerCheck beside a pending customer arbitration naming Wesley Palmer (CRD 6433982). The product at issue is a BDC or interval fund. The allegations are unproven, and no party has paid anything on the claim.
FINRA entered findings against Matt Ward (CRD 2075525) over his trading authority in customer accounts. He consented without admitting or denying them. BrokerCheck also lists settled customer disputes at Alliance Global Partners and Euro Pacific Capital.
A variable annuity and life insurance are the products in a pending claim against Deborah Key (CRD 1236421). Its allegations are unproven, and no money has been paid on it.
Phone:
Fax: 1-954-760-6553
Email: [email protected]